Delivery Order SPE2DB25D3201-SPE2DB26FNNNW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Concerta ER 36 mg tablets (100-count packaging) valued at $2,786.94. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, is scheduled for completion by July 30, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $18,087.66. This firm fixed price, non-set-aside delivery order was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a direct pharmaceutical procurement to support...
- The Defense Logistics Agency awarded a delivery order valued at $31,897.20 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-competitive, firm fixed-price delivery order represents a single-line item pharmaceutical procurement supporting federal medical supply needs. The award was issued without a set-aside designation and will be performed at the contractor's facility...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) valued at $5,783.47, with delivery completion by September 10, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The prime contractor, headquartered in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Concerta ER Tabs 36mg with a ceiling value of $62,578.41. This firm fixed-price, non-set-aside contract is scheduled for completion by September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) valued at $1,047.86 on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed from the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Concerta ER Tablets 36mg with a ceiling value of $15,818.06. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle and involves no set-aside designation. The award was made competitively and will be performed at the...
- On September 16, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $23,558.87 to AmerisourceBergen Drug Corp for the supply of Concerta ER (extended-release) 36 mg tablets. This competitive, firm fixed-price delivery order, which carries no set-aside designation, is scheduled for completion by September 17, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Concerta ER 27 mg tablets (100-count units) with a ceiling value of $6,100.05. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, is set to be completed by May 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $28,591.14 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Concerta ER Tablets 36mg. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract requires completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB26FNNNWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Concerta ER 36 mg tablets in quantities of 100 units, with a contract ceiling value of $8,445.43. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The ultimate completion date is set for October 24, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract reflects DLA's reliance on AmerisourceBergen as a critical vendor for federal medical procurement, particularly for neurological, pain management, and specialty pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 10/23/25 |